Skip to content

An E-health Letter Intervention for Caregivers

Acquired Brain Injury | Caregivers

The purpose of the present study is to conduct a two-arm Randomized Control Trial (RCT) comparing individuals receiving the 90Second Caregiver health letter, with a usual care (routine care received by caregivers) control group.

The goals of the present study are:

* To evaluate the effectiveness of the 90Second Caregiver health letter in improving caregiver's self-efficacy (primary outcome), savouring, and quality of life (secondary outcomes).
* To evaluate the effectiveness of the 90Second Caregiver health letter in reducing caregiver's psychological strain and caregiver burden (secondary outcomes).
* To examine the impact of levels of engagement with the 90Second Caregiver health letter on primary and secondary outcomes.
* To assess the usability of the 90Second Caregiver health letter, as it relates to the relevance of topic, user friendliness, and appropriateness of the readability levels.
* To evaluate psychometric properties of self-constructed measures in 90Second newsletter.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* Participant is currently enrolled in the Caring Forward Trials within Cohort study (REB#1025253)
* Participant has agreed to be contacted for future studies by Dr. McGrath's staff
* Participant has agreed for their data to be used for future studies
* Participant has mild levels of distress, as indicated by mild scores on the DASS-21 and/or the ZBI-SF

Exclusion Criteria:

* Participant is NOT currently enrolled in the Caring Forward Trials within Cohort study (REB#1025253)
* Participant has NOT agreed to be contacted for future studies by Dr. McGrath's staff
* Participant has NOT agreed for their data to be used in future studies
* Participant does NOT report mild levels of distress, as indicated by mild scores on the DASS-21 and/or the ZBI-SF

Lieu de l'étude

IWK Health Centre
IWK Health Centre
Halifax, Nova Scotia
Canada

Contactez l'équipe d'étude

Primary Contact

Andre Lauzon

[email protected]
(902) 470-8160
Étude parrainée par
IWK Health Centre
Participants recherchés
Plus d'informations
ID de l'étude: NCT05882461